Compare AHCO & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHCO | ADNT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | N/A |
| Metric | AHCO | ADNT |
|---|---|---|
| Price | $10.10 | $20.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | $13.60 | ★ $23.10 |
| AVG Volume (30 Days) | 852.0K | ★ 1.3M |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | $3,255,213,000.00 | ★ $14,535,000,000.00 |
| Revenue This Year | $1.07 | $1.86 |
| Revenue Next Year | $6.49 | $2.20 |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.11 | $10.04 |
| 52 Week High | $11.63 | $26.16 |
| Indicator | AHCO | ADNT |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 50.04 |
| Support Level | $9.46 | $20.32 |
| Resistance Level | $10.87 | $22.45 |
| Average True Range (ATR) | 0.36 | 1.00 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 43.49 | 18.90 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.